Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neckThomas Kuhnt, Jürgen Dunst, Peter Hass et al.|Strahlentherapie und Onkologie|2017Cited by 8
Phase II trial of concomitant hyperfractionated-accelerated radiotherapy (HART) with cisplatin (Cis) plus cetuximab (Cet) for locoregionally advanced inoperable squamous cell carcinoma of the head and neck (LA SCCHN): Feasibility and 2-year OS.Thomas Kuhnt, Juergen Dunst, Andreas Schreiber et al.|Journal of Clinical Oncology|2013Cited by 3